207 related articles for article (PubMed ID: 30891247)
21. Impact of the COVID-19 Pandemic on Medical Product Procurement, Prices, and Supply Chain in Zimbabwe: Lessons for Supply Chain Resiliency.
Yemeke TT; Umaru FA; Ferrand RA; Ozawa S
Glob Health Sci Pract; 2023 Oct; 11(5):. PubMed ID: 37903588
[TBL] [Abstract][Full Text] [Related]
22. A new approach to gathering pharmaceutical market data to support policy implementation and access to medicines: as demonstrated by malaria medicines in Zambia.
Coghlan R; Stephens P; Mwale B; Siyanga M
Malar J; 2018 Nov; 17(1):444. PubMed ID: 30497504
[TBL] [Abstract][Full Text] [Related]
23. Pharmaceuticals imports in Tanzania: Overview of private sector market size, share, growth and projected trends to 2021.
Wande DP; Sangeda RZ; Tibalinda P; Mutta IK; Mkumbwa S; Bitegeko A; Kaale E
PLoS One; 2019; 14(8):e0220701. PubMed ID: 31404109
[TBL] [Abstract][Full Text] [Related]
24. Inefficient procurement processes undermine access to medicines in the Western Cape Province of South Africa.
Magadzire BP; Ward K; Leng HMJ; Sanders D
S Afr Med J; 2017 Jun; 107(7):581-584. PubMed ID: 29025446
[TBL] [Abstract][Full Text] [Related]
25. Availability and affordability of antimalarial and antibiotic medicines in Malawi.
Khuluza F; Heide L
PLoS One; 2017; 12(4):e0175399. PubMed ID: 28419126
[TBL] [Abstract][Full Text] [Related]
26. The malaria testing and treatment landscape in mainland Tanzania, 2016.
; Michael D; Mkunde SP
Malar J; 2017 Apr; 16(1):202. PubMed ID: 28521811
[TBL] [Abstract][Full Text] [Related]
27. Rethinking health sector procurement as developmental linkages in East Africa.
Mackintosh M; Tibandebage P; Karimi Njeru M; Kariuki Kungu J; Israel C; Mujinja PGM
Soc Sci Med; 2018 Mar; 200():182-189. PubMed ID: 29421465
[TBL] [Abstract][Full Text] [Related]
28. Baseline assessment of WHO's target for both availability and affordability of essential medicines to treat non-communicable diseases.
Ewen M; Zweekhorst M; Regeer B; Laing R
PLoS One; 2017; 12(2):e0171284. PubMed ID: 28170413
[TBL] [Abstract][Full Text] [Related]
29. Prices & availability of common medicines at six sites in India using a standard methodology.
Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of prices, availability and affordability of essential medicines in Lahore Division, Pakistan: A cross-sectional survey using WHO/HAI methodology.
Saeed A; Saeed H; Saleem Z; Fang Y; Babar ZU
PLoS One; 2019; 14(4):e0216122. PubMed ID: 31022276
[TBL] [Abstract][Full Text] [Related]
31. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
[TBL] [Abstract][Full Text] [Related]
32. The procurement and supply chain strengthening project: improving public health supply chains for better access to HIV medicines, Uganda 2011-2016.
Muyingo S; Etoori D; Lotay P; Malamba S; Olweny J; Keesler K; Wiersma S; Jjemba P; Settaala R
J Pharm Policy Pract; 2022 Oct; 15(1):72. PubMed ID: 36303238
[TBL] [Abstract][Full Text] [Related]
33. Are essential medicines in Malaysia accessible, affordable and available?
Saleh K; Ibrahim MI
Pharm World Sci; 2005 Dec; 27(6):442-6. PubMed ID: 16341951
[TBL] [Abstract][Full Text] [Related]
34. Health system's barriers hindering implementation of public-private partnership at the district level: a case study of partnership for improved reproductive and child health services provision in Tanzania.
Kamugumya D; Olivier J
BMC Health Serv Res; 2016 Oct; 16(1):596. PubMed ID: 27769234
[TBL] [Abstract][Full Text] [Related]
35. Testing times: trends in availability, price, and market share of malaria diagnostics in the public and private healthcare sector across eight sub-Saharan African countries from 2009 to 2015.
; Hanson K; Goodman C
Malar J; 2017 May; 16(1):205. PubMed ID: 28526075
[TBL] [Abstract][Full Text] [Related]
36. Initial success and substantial government savings may mandate prime vendor contracts for Table of Organization and Equipment units and development support.
Rembold JM; Berry TR
Mil Med; 1997 Jan; 162(1):68-70. PubMed ID: 9002708
[TBL] [Abstract][Full Text] [Related]
37. An evaluation of South Africa's public-private partnership for the localisation of vaccine research, manufacture and distribution.
Walwyn DR; Nkolele AT
Health Res Policy Syst; 2018 Mar; 16(1):30. PubMed ID: 29587777
[TBL] [Abstract][Full Text] [Related]
38. Access and Affordability of Medicines in Malaysia: Need for a National Pricing Policy.
Wong SL; Ibrahim S; Abdul Kadir N; Mohd Salleh S
Appl Health Econ Health Policy; 2019 Oct; 17(5):641-654. PubMed ID: 31093937
[TBL] [Abstract][Full Text] [Related]
39. Has Tanzania embraced the green leaf? Results from outlet and household surveys before and after implementation of the Affordable Medicines Facility-malaria.
Thomson R; Festo C; Johanes B; Kalolella A; Bruxvoort K; Nchimbi H; Tougher S; Cairns M; Taylor M; Kleinschmidt I; Ye Y; Mann A; Ren R; Willey B; Arnold F; Hanson K; Kachur SP; Goodman C
PLoS One; 2014; 9(5):e95607. PubMed ID: 24816649
[TBL] [Abstract][Full Text] [Related]
40. How well does Malaysia achieve value for money in public sector purchasing of medicines? Evidence from medicines procurement prices from 2010 to 2014.
Hamzah NM; Perera PN; Rannan-Eliya RP
BMC Health Serv Res; 2020 Jun; 20(1):509. PubMed ID: 32503539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
